Literature DB >> 11469988

Diarrhea- and Constipation-predominant Irritable Bowel Syndrome.

Richard Lea1, Peter J. Whorwell.   

Abstract

Irritable bowel syndrome (IBS) has a reputation for being hard to treat, trivial, and often psychologic in origin. Furthermore, there currently appears to be almost more of a stigma attached to being diagnosed as having IBS than a depressive illness. Thus, it is not surprising that patients with this syndrome become distressed by the attitudes they encounter, particularly as we now know that this condition can substantially impair one's quality of life. The problem with effective management is that there is no "standard treatment" and therapy has to be targeted to the symptoms of the individual patient. This frequently proves to be time consuming and also may involve some degree of trial and error. However, when all the issues surrounding IBS are addressed in a sympathetic and positive manner, these patients can be surprisingly rewarding to treat.

Entities:  

Year:  2001        PMID: 11469988     DOI: 10.1007/s11938-001-0055-x

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  50 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Irritable colon and depression.

Authors:  J D Heefner; R M Wilder; I D Wilson
Journal:  Psychosomatics       Date:  1978-09       Impact factor: 2.386

3.  Mebeverine in patients with the irritable colon syndrome: double blind study.

Authors:  C Tasman-Jones
Journal:  N Z Med J       Date:  1973-04

4.  Psychologic Therapies for Irritable Bowel Syndrome.

Authors:  Philip Boyce
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

5.  Evaluation of tricyclic compound (trimipramine) vis-a-vis placebo in irritable bowel syndrome. (Double blind randomised study).

Authors:  B M Tripathi; N P Misra; A K Gupta
Journal:  J Assoc Physicians India       Date:  1983-04

6.  Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.

Authors:  W Kruis; M Weinzierl; P Schüssler; J Holl
Journal:  Digestion       Date:  1986       Impact factor: 3.216

7.  Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose.

Authors:  F A Lederle; D L Busch; K M Mattox; M J West; D M Aske
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

8.  Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome.

Authors:  D A Gorard; G W Libby; M J Farthing
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

9.  Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity.

Authors:  M J Lancaster-Smith; B J Prout; T Pinto; J A Anderson; A A Schiff
Journal:  Acta Psychiatr Scand       Date:  1982-07       Impact factor: 6.392

10.  Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.

Authors:  T Poynard; S Naveau; B Mory; J C Chaput
Journal:  Aliment Pharmacol Ther       Date:  1994-10       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.